We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+7.76%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.75B
AUM Growth
+$529M
Cap. Flow
-$138M
Cap. Flow %
-2.91%
Top 10 Hldgs %
47.97%
Holding
745
New
128
Increased
150
Reduced
259
Closed
162

Top Buys

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$253M
2
PDCE
PDC Energy, Inc.
PDCE
+$210M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$206M
4
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$135M
5
LSI
Life Storage, Inc.
LSI
+$87.5M

Top Sells

Rank Stock Value
1
FHN icon
First Horizon
FHN
+$179M
2
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
+$146M
3
PRVB
Provention Bio, Inc. Common Stock
PRVB
+$70.5M
4
TSEM icon
Tower Semiconductor
TSEM
+$50.8M
5
XM
Qualtrics International Inc. Class A Common Stock
XM
+$45.3M

Sector Composition

Rank Sector Weight
1 Healthcare 32.35%
2 Technology 15.53%
3 Financials 11.99%
4 Real Estate 8.48%
5 Materials 5.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NAVI icon
526
PUT
Navient
NAVI
$848M
$10.5K ﹤0.01%
60,000
– –
TRONW
527
DELISTED
Corner Growth Acquisition Corp. 2 Warrants
TRONW
$10.3K ﹤0.01%
116,665
-1,321
-1% -$110
AKTS
528
CALL
DELISTED
Akoustis Technologies Inc
AKTS
$10K ﹤0.01%
100,000
– –
JTAIW
529
DELISTED
Jet.AI Inc. Warrant
JTAIW
$9.57K ﹤0.01%
197,427
-6,425
-3% -$306
BOAC.WS
530
DELISTED
Bluescape Opportunities Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
BOAC.WS
$9.56K ﹤0.01%
226,519
-5,112
-2% -$372
AEON.WS
531
DELISTED
AEON Biopharma Inc
AEON.WS
$9.26K ﹤0.01%
108,918
-3,555
-3% -$267
JWSM.WS
532
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$9.2K ﹤0.01%
172,581
-3,898
-2% -$229
MCAAW
533
DELISTED
Mountain & Co. I Acquisition Corp. Warrant
MCAAW
$9.07K ﹤0.01%
136,155
-4,432
-3% -$311
ENERR
534
DELISTED
Accretion Acquisition Corp Right
ENERR
$9.01K ﹤0.01%
97,876
-3,213
-3% -$357
FSRXW
535
DELISTED
FinServ Acquisition Corp. II Warrant
FSRXW
$8.45K ﹤0.01%
305,055
-1,194
-0.4% -$40
CSTA.WS
536
DELISTED
Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CSTA.WS
$8.18K ﹤0.01%
139,600
-4,556
-3% -$398
TVGNW icon
537
Tevogen Inc. Warrant
TVGNW
$814K
$7.74K ﹤0.01%
186,593
-6,072
-3% -$328
SEDA.WS
538
DELISTED
SDCL EDGE Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A ordinary share at an exercise price of $11.50
SEDA.WS
$7.51K ﹤0.01%
71,043
-1,601
-2% -$175
APXIW
539
DELISTED
APx Acquisition Corp. I Warrant
APXIW
$7.25K ﹤0.01%
91,439
-2,975
-3% -$235
DISAW
540
DELISTED
Disruptive Acquisition Corporation I Warrant
DISAW
$7.15K ﹤0.01%
84,138
-2,738
-3% -$229
PUCKW
541
DELISTED
Goal Acquisitions Corp. Warrant
PUCKW
$7.08K ﹤0.01%
283,281
-3,485
-1% -$111
BSLKW
542
DELISTED
Bolt Projects Holdings Warrant
BSLKW
$6.49K ﹤0.01%
165,963
-5,401
-3% -$231
SFRWW
543
DELISTED
Appreciate Holdings, Inc. Warrant
SFRWW
$6.37K ﹤0.01%
230,109
-7,510
-3% -$285
GLTA.WS
544
DELISTED
Galata Acquisition Corp. Warrants, each whole warrant exercisable for one class A ordinary share at an exercise price of $11.50
GLTA.WS
$6.37K ﹤0.01%
115,551
-3,761
-3% -$277
FICVW
545
DELISTED
Frontier Investment Corp Warrants
FICVW
$6.26K ﹤0.01%
32,524
-1,058
-3% -$162
SDACW
546
DELISTED
Sustainable Development Acquisition I Corp. Warrant
SDACW
$6.1K ﹤0.01%
116,160
-3,791
-3% -$172
IFIN.WS
547
DELISTED
InFinT Acquisition Corporation Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per whole share
IFIN.WS
$6.03K ﹤0.01%
115,551
-2,604
-2% -$148
ARBGW
548
DELISTED
Aequi Acquisition Corp warrants
ARBGW
$4.68K ﹤0.01%
153,405
-5,006
-3% -$442
AENTW icon
549
Alliance Entertainment Holding Corp Warrants
AENTW
$4.27M
$4.61K ﹤0.01%
+116,781
New +$5.49K
FNVTW
550
DELISTED
Finnovate Acquisition Corp. Warrants
FNVTW
$4.58K ﹤0.01%
130,406
-4,245
-3% -$181
20 21
22
23 24

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q2 2023 Portfolio in Review

As of Q2 2023, UBS O'Connor held 745 positions worth $4.75B, up 13% from $4.22B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

UBS O'Connor's Q2 2023 filing shows 128 new, 150 increased, 259 reduced and 162 closed positions. Its largest new stake was PDC Energy, Inc.: 3,101,445 shares worth $221M. The largest sale was First Horizon, an estimated $179M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 21% a quarter earlier, followed by Technology and Financials.

  • UBS O'Connor's largest Q2 2023 buy was PDC Energy, Inc.: 3,101,445 shares worth $221M.
  • UBS O'Connor added most to Seagen Inc. Common Stock in Q2 2023, an estimated $253M increase.
  • UBS O'Connor's biggest Q2 2023 reduction was Tower Semiconductor, cutting an estimated $50.8M.
  • UBS O'Connor fully exited First Horizon in Q2 2023, selling an estimated $179M.
  • UBS O'Connor's ten largest holdings make up 48% of its $4.75B portfolio in Q2 2023.
  • UBS O'Connor opened 128 new positions and closed 162 in Q2 2023.
  • UBS O'Connor's portfolio value rose 13% quarter-over-quarter to $4.75B.

Based on UBS O'Connor's 13F filing for Q2 2023, filed 14 Aug 2023.